In CEACAM1 null mice, the absence of CEACAM1 led to an inability to clear insulin, leading to hyperinsulinemia followed by insulin resistance, obesity, and non-alcoholic steatohepatitis [120]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.